LoadingLoadingLoadingThe quick read
Latest quote·Oct 12
No insider open-market trades in 90 days (SEC Form 4). Congress: net buying of $1K to $15K in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsNeither. Quantinuum Inc. Class A Common Stock (QNT) insiders filed no open-market purchases or sales in the 90 days to Oct 14, 2026, according to SEC Form 4 filings.
Rep. Cleo Fields (D) bought $1K to $15K on Jun 4, 2026, disclosed 22 days later. In total, 1 member disclosed 1 QNT trade with trade dates in the last 180 days, filed a median 22 days after trading.
This summary uses filings available on Oct 14, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
8 funds hold a position and insiders have been net buying.
Buys (1)
No tracked top-trader positions in QNT right now.
Live Hyperliquid positioning - not every stock is covered
Last report
Aug 11, 2026
Period ending
Jun 30, 2026
Adjusted EPS
-$0.26 expected
Revenue
No reported revenue on record
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 11, 2026 | -$0.28 / -$0.26Yahoo Finance | -8.21% miss | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Estimates as of Oct 14, 2026
EPS expected
-$0.49 to -$0.31
Revenue expected
12 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
This company is running thin margins.
Valuation
Quality
Growth
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
